SAN FRANCISCO, Sept. 6, 2016 /PRNewswire/ -- Kaiser and Takeda join Health 2.0's MarketConnect: a vetted buyer-seller forumfor health technology. Through vigorous vetting of health technology companies and matching based on prospective buyer's needs, Health 2.0 is simplifying and expediting the health tech buying and selling process during their 10th Annual Fall Conference
A first of its kind, Health 2.0's MarketConnect is an invitation only forum for buyers and sellers to be pre-matched for market compatibility and facilitate technology acquisition. Executives from organizations such as Kaiser Permanente, Lumos Labs, Takeda Pharmaceuticals and more will be looking for to connect with technology companies.
The networking program is designed to break down the barriers of technology adoption within large health systems and health organizations to connect tech companies directly with pre-qualified executives that are interested in seeing vetted technologies that are relevant to problems that are trying to solve.
How it works: Health 2.0 works with closely with buyers to identify specific areas where technology is needed and a solution is required within 12 months. Health 2.0 then assess the digital health marketplace and identifies relevant companies aligned with buyer's' technology needs and connect buyers with hand-picked companies during our MarketConnect event at Health 2.0's Annual Fall Conference. During the event, buyers will meet with up to 5 compatible companies with the intent of purchasing suitable technologies.
More for information about MarketConnect and the 10th Annual Fall Conference, go to www.health2con.com.
About Health 2.0Health 2.0 is the premiere showcase and catalyst for the advancement of new health technologies. Through a global series of conferences, thought leadership roundtables, developer competitions, pilot programs, and leading market intelligence, Health 2.0 drives the innovation and collaboration necessary to transform health and health care.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/health-20-is-expediting-the-health-technology-buying-process-300323062.html
SOURCE Health 2.0
Subscribe to our Free Newsletters!
Angiogenesis is the process of formation of new blood vessels from pre-existing blood vessels. It ...
Aniridia is a genetic eye disorder in which the iris is partially or entirely absent. It is ...
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...View All